Physician profile
Brian E Smith
NPI 1588646194
$424.86
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $33.05 · 2021: $17.98.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $81.14 | 2019 | |
| Omeros Corporation | $73.62 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.11 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $41.88 | 2019 | |
| Alcon Vision LLC | $40.00 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $32.41 | 2019 | |
| Allergan, INC. | $30.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.29 | 2019 | |
| Akorn, INC. | $16.90 | 2019 | |
| Ocular Therapeutix, INC. | $13.69 | 2019 | |
| Abbvie INC. | $12.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.